PALO ALTO, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results